Pliant Therapeutics Inc.

NASDAQ: PLRX · Real-Time Price · USD
1.54
-0.03 (-2.22%)
At close: Aug 15, 2025, 3:59 PM
1.54
-0.32%
After-hours: Aug 15, 2025, 05:57 PM EDT

Pliant Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-206.96M -219.51M -210.3M -201.68M -185.41M -170.74M -161.34M -155.29M -144.41M -132.77M -123.32M -112.79M -109.22M -102.51M -97.26M -91.76M -81.25M -75.42M
Depreciation & Amortization
1.89M 2.06M 2.13M 2.13M 2.05M 1.9M 1.84M 1.83M 1.84M 1.82M 1.82M 1.79M 1.72M 1.63M 1.53M 1.46M 1.41M 1.36M
Stock-Based Compensation
32.61M 36.87M 37.63M 38.36M 39.82M 42.23M 44.48M 46.19M 40.63M 30.99M 22.6M 14.51M 12.51M 11.39M 10.44M 9.18M 7.54M 6.05M
Other Working Capital
-3.3M 1.29M 7.66M 14.35M -1.25M 445K -573K -4.45M 4.06M 6.43M 5.55M 8.95M 6.6M 712K 260.42M 261.44M 260.36M 259.96M
Other Non-Cash Items
8.15M 6.36M 5.96M 2.74M 1.52M 1.15M -2.6M -1.7M -2.42M -2.61M -119K 2.84M 3.36M 3.18M 2.93M 1.18M 1.95M 1.36M
Deferred Income Tax
n/a n/a n/a 7.63M 3.93M n/a n/a -7.63M -3.93M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-5.09M 122K 9.09M 17.88M 1.19M 9.11M 1.25M -5.9M 3.52M -2.01M 4.22M 10.22M 4.19M 4.03M 6.92M 7.87M 6.16M 29.31M
Operating Cash Flow
-169.4M -174.1M -155.5M -132.94M -136.89M -116.36M -116.36M -122.5M -104.77M -104.41M -94.63M -83.26M -87.27M -82.28M -75.44M -72.06M -65.34M -38.17M
Capital Expenditures
-1.48M -2.62M -3.85M -3.7M -2.9M -2.25M -921K -1.03M -1.63M -1.28M -1.76M -2.19M -1.97M -2.35M -1.95M -1.95M -1.79M -1.44M
Cash Acquisitions
n/a n/a n/a -158.07M -196.42M -174.04M n/a 137.88M 353.79M 331.41M 157.37M 177.56M n/a n/a n/a 24M 24M 24M
Purchase of Investments
-176.14M -173.06M -211.28M -235.43M -272.87M -358.82M -583.07M -561.89M -658.76M -563.11M -325.72M -327.32M -159.1M -194.31M -219.89M -236.75M -320.37M -376.37M
Sales Maturities Of Investments
352.32M 325.58M 355.47M 372.26M 416.19M 467.82M 456.98M 424M 304.98M 238.44M 177.27M 185.06M 226.98M 259.66M 295.54M 298.52M 244.8M 190.55M
Other Investing Acitivies
n/a n/a n/a 158.07M 196.42M 174.04M n/a -137.88M -353.79M -324.66M -148.44M -142.26M 67.88M 65.35M 75.65M 25.28M -112.06M -92.28M
Investing Cash Flow
174.69M 149.91M 140.34M 133.13M 140.42M 106.74M -127.01M -138.91M -355.42M -325.94M -150.2M -144.44M 65.91M 63M 73.7M 59.82M -77.36M -187.26M
Debt Repayment
1K 1K 19.91M 19.91M 19.91M 19.91M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -1.88M -1.88M -1.89M -1.97M -3.92M -847K -605K -1.74M 12.52M 9.29M 9.04M 8.25M -1.98M -457K -195K 1.8M 165.25M
Financial Cash Flow
1.14M 1.83M 23.12M 23.23M 23.39M 22.87M 274.4M 274.47M 490.07M 500.33M 226.85M 227.09M 11.24M 1M 2.53M 2.25M -566K 162.88M
Net Cash Flow
6.43M -22.36M 7.95M 23.42M 26.92M 13.25M 31.03M 13.06M 29.88M 69.98M -17.98M -614K -10.12M -18.27M 783K -9.99M -143.27M -62.55M
Free Cash Flow
-170.88M -176.71M -159.35M -136.64M -139.79M -118.61M -117.28M -123.52M -106.4M -105.69M -96.39M -85.44M -89.24M -84.63M -77.4M -74.01M -67.14M -39.61M